Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

The South Wales, UK contained-manufacturing operation was built in less than a year using design-to-manufacture and modular approaches.

Penn Pharma Opens Manufacturing Facility for Highly Potent Compounds

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Adoption of single-use systems and more flexible systems drive innovation.

The Next Generation in Aseptic-Filling Equipment

Greater automation and the adoption of solid versus perforated pans are some recent advances.

Raising the Bar in Tablet Coating Equipment and Processing

Dynamic testing and advances in shear testing provide better insight into powder physical properties and external variables that affect powder behavior.

Multivariate Approaches for Powder Characterization

Crushing, fracturing, and bending tests quantify hardness.

Measuring Tablet Hardness: A Primer

Thomson Reuters released a report that provides a view of the challenges facing companies entering the United States biosimilar drug market.

Report Previews Future of U.S. Biosimilar Market

Drug manufacturers today are increasingly challenged to find new, effective methods for the delivery of active pharmaceutical ingredients, and many are discovering that orally disintegrating technologies can help.

Orally Disintegrating Tablets

Advances in monoclonal antibody separation technologies are largely driven by the need to increase efficiencies and reduce cost.

Improving the Economics of Monoclonal Antibody Separation

New platform technologies and polymer chemistries may facilitate self-administration, longer-term delivery, and targeted delivery of parenteral drugs.

Advances in Biodegradable Polymer Technologies Facilitate Sustained Release of Parenteral Drugs

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The Global Vaccine Action plan maps out a strategy to increase access and R&D for vaccines.